Cameron lesions and selective serotonin reuptake inhibitors: An uncommon combination

Gastroenterol Hepatol. 2020 May;43(5):264-265. doi: 10.1016/j.gastrohep.2019.11.007. Epub 2020 Feb 13.

[Article in English, Spanish]

Authors

Marta Izquierdo Romero¹, Jorge Rodríguez Prida², Benito Hermida Pérez³, Zhuraida Salman Monte³

Affiliations

¹ Servicio de Aparato Digestivo, Hospital Universitario de Cabueñes, Gijón, Asturias, España. Electronic address: martaizquierdoromero@gmail.com.
² Servicio de Medicina Interna, Hospital Universitario de Cabueñes, Gijón, Asturias, España.
³ Servicio de Aparato Digestivo, Hospital Universitario de Cabueñes, Gijón, Asturias, España.

PMID: 32063438
DOI: 10.1016/j.gastrohep.2019.11.007

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Anxiety Disorders / drug therapy
Female
Fluoxetine / adverse effects*
Gastrointestinal Hemorrhage / chemically induced
Gastrointestinal Hemorrhage / etiology*
Gastroscopy
Hernia, Hiatal / complications*
Humans
Melena / etiology
Olanzapine / adverse effects*
Proton Pump Inhibitors / therapeutic use
Selective Serotonin Reuptake Inhibitors / adverse effects*
Stomach Ulcer / complications
Stomach Ulcer / diagnosis*
Stomach Ulcer / drug therapy

Substances

Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Fluoxetine
Olanzapine